| Literature DB >> 32110606 |
Montosh Chakraborty1, Prerna Singh2, Jyothi M P Dsouza2, Karthikeyan Pethusamy3, Pandurang V Thatkar4.
Abstract
CONTEXT: Dyslipidemia plays a crucial role in atherogenesis, in both prediabetes and diabetes. There persists a lacuna in the evaluation of postprandial lipid parameters in prediabetes. AIMS: To comparatively evaluate fasting and postprandial blood lipid parameters and atherogenic lipid ratios for cardiovascular risk assessment, in prediabetes and diabetes.Entities:
Keywords: Diabetes; dyslipidemia; fasting lipid profile; postprandial lipid profile; prediabetes
Year: 2020 PMID: 32110606 PMCID: PMC7014867 DOI: 10.4103/jfmpc.jfmpc_769_19
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Demographic data in the study groups
| Number | Percentage | Age in years (gender-wise) | Average age in years | |||
|---|---|---|---|---|---|---|
| Control | Male | 13 | 46.4% | 53 | 49.43 | |
| Female | 15 | 53.5% | 46 | |||
| Prediabetics | Male | 16 | 50% | 55 | 54.41 | |
| Female | 16 | 50% | 53 | |||
| Diabetics | Male | 28 | 54.9% | 52 | 55.53 | |
| Female | 23 | 45.1% | 58 |
Fasting glycemic indices and fasting lipid parameters in the study groups
| Controls | Prediabetes | Diabetes | ||
|---|---|---|---|---|
| HbA1c (%) | 5.1±0.35 | 5.7±0.47 | 7.0±0.88 | <0.001 |
| FBG (mg/dl) | 85.7±9.2 | 106.7±11.9 | 167.5±73.6 | <0.001 |
| TC (mg/dl) | 169.8±35.4 | 173.6±35.0 | 196.7±41.2 | <0.01 (C: D) |
| TG (mg/dl) | 113.5±68.9 | 119.6±51.7 | 147.7±65.9 | Not significant |
| HDLc (mg/dl) | 44.8±8.6 | 46.5±8.7 | 47.7±8.3 | Not significant |
| LDLc (mg/dl) | 102.3±33.9 | 103.0±33.3 | 119.4±38.9 | Not significant |
| TC/HDLc | 3.9±0.91 | 3.82±0.95 | 4.2±1.09 | Not significant |
| LDLc/HDLc | 2.31±0.79 | 2.30±0.92 | 2.59±1.01 | Not significant |
| TG/HDLc | 2.9±2.9 | 2.62±1.3 | 3.2±1.3 | Not significant |
C=controls, P=prediabetes, D=diabetes
Postprandial glycemic indices, postprandial lipid parameters in the study groups
| Controls | Prediabetes | Diabetes | ||
|---|---|---|---|---|
| PPBG (mg/dl) | 120.7±21.3 | 155.9±28.8 | 256.1±73.2 | <0.001 (P: D, C: D) |
| TC (mg/dl) | 171.5±35.4 | 175.1±39.0 | 190.0±48.4 | Not significant |
| TG (mg/dl) | 136.2±74.7 | 150.5±56.0 | 191.8±77.0 | <0.01 (C: D) |
| HDLc (mg/dl) | 49.6±11.7 | 47.8±9.2 | 47.3±10.1 | Not significant |
| LDLc (mg/dl) | 94.6±34.9 | 97.2±37.8 | 104.3±46.7 | Not significant |
| TC/HDLc | 3.6±1.02 | 3.8±1.02 | 4.1±1.15 | Not significant |
| LDLc/HDLc | 2.0±0.83 | 2.1±0.97 | 2.3±1.08 | Not significant |
| TG/HDLc | 3.1±2.68 | 3.3±1.54 | 4.3±1.84 | <0.05 (C: D) |
C=controls, P=prediabetes, D=diabetes
Intragroup analysis of lipid parameters and blood glucose
| Controls | Prediabetes | Diabetes | ||
|---|---|---|---|---|
| Blood glucose | Fasting | 85.7±9.2 | 106.7±11.9 | 167.5±73.6 |
| Postprandial | 120.7±21.3 | 155.9±28.8 | 256.1±73.2 | |
| 0.000*** | 0.000*** | 0.000*** | ||
| TC | Fasting | 169.8±35.4 | 173.6±35.0 | 196.7±41.2 |
| Postprandial | 171.5±35.4 | 175.1±39.0 | 190.0±48.4 | |
| 0.438 | 0.699 | 0.089 | ||
| TG | Fasting | 113.5±68.9 | 119.6±51.7 | 147.7±65.9 |
| Postprandial | 136.2±74.7 | 150.5±56.0 | 191.8±77.0 | |
| 0.000*** | 0.000*** | 0.000*** | ||
| HDLc | Fasting | 44.8±8.6 | 46.5±8.7 | 47.7±8.3 |
| Postprandial | 49.6±11.7 | 47.8±9.2 | 47.3±10.1 | |
| 0.008** | 0.321 | 0.605 | ||
| LDLc | Fasting | 102.3±33.9 | 103.0±33.3 | 119.4±38.9 |
| Postprandial | 94.6±34.9 | 97.2±37.8 | 104.3±46.7 | |
| 0.002** | 0.157 | 0.000*** | ||
| TC/HDLc | Fasting | 3.9±0.91 | 3.82±0.95 | 4.2±1.09 |
| Postprandial | 3.6±1.02 | 3.8±1.02 | 4.1±1.15 | |
| 0.020* | 0.577 | 0.246 | ||
| LDLc/HDLc | Fasting | 2.31±0.79 | 2.30±0.92 | 2.59±1.01 |
| Postprandial | 2.0±0.83 | 2.1±0.97 | 2.3±1.08 | |
| 0.000*** | 0.053 | 0.000*** | ||
| TG/HDLc | Fasting | 2.9±2.9 | 2.62±1.3 | 3.2±1.3 |
| Postprandial | 3.1±2.68 | 3.3±1.54 | 4.3±1.84 | |
| 0.325 | 0.000*** | 0.000*** |
* P<0.05, ** P<0.01, *** P<0.001
Pearson’s correlation analysis of fasting and postprandial lipid parameters with HbA1c
| TC | TG | HDLC | LDLC | TC/HDLC | TG/HDLC | LDLC/HDLC | |
|---|---|---|---|---|---|---|---|
| Fasting profile | |||||||
| 0.189 | 0.226 | 0.091 | 0.105 | 0.111 | 0.101 | 0.079 | |
| 0.046* | 0.017* | 0.343 | 0.273 | 0.246 | 0.292 | 0.412 | |
| Postprandial profile | |||||||
| 0.094 | 0.280 | -0.129 | 0.029 | 0.161 | 0.260 | 0.076 | |
| 0.324 | 0.003** | 0.178 | 0.761 | 0.090 | 0.006** | 0.429 |
* P<0.05, ** P<0.01
Prevalence of dyslipidemia and insulin resistance in the study groups
| Controls | Prediabetes | Diabetes | |
|---|---|---|---|
| Prevalence of dyslipidemia | |||
| Fasting TG (≥150 mg/dl) | 5 (17.8%) | 7 (22.5%) | 21 (41.1%) |
| Postprandial TG (≥175 mg/dl) | 5 (17.8%) | 9 (29.03%) | 28 (54.9%) |
| Prevalence of insulin resistance | |||
| TG/HDLc (Fasting≥3.5) | 3 (10.7%) | 4 (12.5%) | 17 (33.3%) |
| TG/HDLc (Postprandial≥3.5) | 6 (21.4%) | 10 (31.25%) | 30 (58.8%) |